奥西默替尼
医学
肺癌
癌症研究
肿瘤科
内科学
表皮生长因子受体
癌症
埃罗替尼
作者
Yi−Long Wu,Masahiro Tsuboi,Jie He,Thomas John,Christian Grohé,Margarita Majem,Jonathan W. Goldman,К. К. Лактионов,Sang‐We Kim,Terufumi Kato,Huu-Vinh Vu,Shun Lü,Kye Young Lee,Charuwan Akewanlop,Chong‐Jen Yu,Filippo de Marinis,Laura Bonanno,Manuel Dómine,Frances A. Shepherd,Lingmin Zeng
标识
DOI：10.1056/nejmoa2027071
摘要
Osimertinib is standard-of-care therapy for previously untreated epidermal growth factor receptor (EGFR) mutation–positive advanced non–small-cell lung cancer (NSCLC). The efficacy and safety of osimertinib as adjuvant therapy are unknown.
科研通智能强力驱动
Strongly Powered by AbleSci AI
请叫我风吹麦浪
Oracle
SYLH
Jackylee
cdercder
pluto
HEIKU
亘古匆匆
迷人秋烟
LYSM
彭于彦祖
斯寜
bc
妞妞公主喜欢派大星
小白
昏睡的蟠桃
子车茗
zp560
nozero
子凡
皖公网安备34019202002308
